35 Results for "

NADPH-dependent 3

" in MedChemExpress (MCE) Product Catalog:
Products (35)

35 Results for "NADPH-dependent 3" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-100986
CAS No.: 159190-44-0
Purity:  ≥97.0%
Target:  

NO Synthase

Research Areas:  

Cardiovascular Disease

L-NIO dihydrochloride is a potent, non-selective and NADPH-dependent nitric oxide synthase (NOS) inhibitor, with Kis of 1.7, 3.9, 3.9 μM for neuronal (nNOS), endothelial (eNOS), and inducible (iNOS), respectively . L-NIO dihydrochloride induces a consistentfocal ischemic infarctin rats .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-12119
CAS No.: 210354-22-6
Purity:  ≥98.0%
Target:  

NO Synthase

GW274150 is a potent, selective, orally active and NADPH-dependent inhibitor of human inducible nitric oxide synthase (iNOS) (IC50=2.19 μM; Kd=40 nM) and rat iNOS (ED50=1.15 μM). GW274150 also displays less potency for both humans or rats endothelial NOS (eNOS) and neuronal NOS (nNOS). GW274150 exerts a protective role in an acute model of lung injury inflammation .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-12119A
CAS No.: 438542-15-5
Purity:  99.85%
Target:  

NO Synthase

GW274150 phosphate is a potent, selective, orally active and NADPH-dependent inhibitor of human inducible nitric oxide synthase (iNOS) (IC50=2.19 μM; Kd=40 nM) and rat iNOS (ED50=1.15 μM). GW274150 phosphate displays less potency for both humans or rats endothelial NOS (eNOS) and neuronal NOS (nNOS). GW274150 phosphate exerts a protective role in an acute model of lung injury inflammation .
loading...
    loading...
Cat. No.: HY-W006230
CAS No.: 84-60-6
Target:  

Cytochrome P450

Research Areas:  

Cancer

Anthraflavic acid specifically inhibits the activity of cytochrome P-448 without affecting phenobarbital-induced cytochrome P-450 or NADPH-dependent cytochrome c reduction. Anthraflavic acid inhibits cytosolic metabolic pathways, blocks the microsomal and cytosolic activation of IQ, and reduces the metabolic activation level of Glu-P-I. Anthraflavic acid may exert anticancer activity by inhibiting the metabolic activation of chemical carcinogens. Anthraflavic acid is applicable to cancer-related research [3].
loading...
    loading...
Cat. No.: HY-122940
CAS No.: 644-06-4
Purity:  99.95%
Synonyms: Ageratochromene
Precocene II (Ageratochromene) is a plant larva hormone antagonists that inhibits the biosynthesis of juvenile hormone. Precocene II inhibits corpora allata function and downregulates juvenile hormone levels, while exerting multiple effects including inducing precocious metamorphosis, forming macropterous morphs, inhibiting ovarian growth, producing cytotoxicity, disrupting insect development, and causing sterility and kidney damage. Precocene II blocks normal nymphal development, causes renal tubular damage and increases blood urea nitrogen levels, and also blocks juvenile hormone biosynthesis in vitro. Precocene II undergoes oxidative metabolism catalyzed by NADPH-dependent monooxygenase to generate a variety of metabolites. Precocene II can be applied in studies related to insect growth regulation and nephrotoxicity [3] .
loading...
    loading...
Cat. No.: HY-P2759
CAS No.: 9074-14-0
Synonyms: TrxR
Target:  

TrxR NADPH Oxidase

Research Areas:  

Cancer

Thioredoxin reductase (TrxR) is a selenocysteine-containing NADPH-dependent disulfide oxidoreductase derived from rat liver that utilizes NADPH to reduce oxidized thioredoxin. Thioredoxin reductase can utilize the reducing capacity of human erythrocytes to study the uptake and reduction of α-Lipoic Acid (HY-N0492), and can also be used to investigate the activation mechanism of transglutaminase 2 (TG2) in the extracellular matrix using thioredoxin [3].
loading...
    loading...
Cat. No.: HY-N2620
CAS No.: 33237-37-5
Rutaevin is an antifungal toxin and CYP3A4 inactivator. Rutaevin requires NADPH-dependent bioactivation to generate cis-but-2-ene-1,4-dial, which then covalently modifies and mechanism-based inactivates human CYP3A4 (IC50=4.48 μM, Ki=15.98 μM), and interacts with substances such as glutathione. Rutaevin disrupts the cellular structure of Sirococcus conigenus, accumulates linearly in resistant larch after pathogen exposure, and induces liver toxicity in mice via oral administration. Rutaevin can be applied to research in fields related to larch shoot blight and other associated areas .
loading...
    loading...
Cat. No.: HY-100986B
CAS No.: 36889-13-1
Target:  

NO Synthase

Research Areas:  

Cardiovascular Disease

L-NIO is a potent, non-selective and NADPH-dependent nitric oxide synthase (NOS) inhibitor, with Kis of 1.7, 3.9, 3.9 μM for neuronal (nNOS), endothelial (eNOS), and inducible (iNOS), respectively . L-NIO induces a consistentfocal ischemic infarctin rats .
loading...
    loading...
Cat. No.: HY-174144
CAS No.: 2851993-73-0
Research Areas:  

Inflammation/Immunology

RJG-2036 is a potent covalent inhibitor of human prostaglandin reductase 2 (PTGR2)(IC50=100 nM). RJG-2036 inhibits NADPH-dependent reduction, significantly reducing secretion of proinflammatory cytokines like TNF-α and multiple eicosanoids in LPS-stimulated THP-1 macrophages. RJG-2036 is promising for research of inflammatory diseases .
loading...
    loading...
Cat. No.: HY-12119B
CAS No.: 438542-17-7
Target:  

NO Synthase

GW274150 (dihydrochloride) is a potent, selective, orally active and NADPH-dependent inhibitor of human inducible nitric oxide synthase (iNOS) (IC50=2.19 μM; Kd=40 nM) and rat iNOS (ED50=1.15 μM). GW274150 (dihydrochloride) displays less potency for both humans or rats endothelial NOS (eNOS) and neuronal NOS (nNOS). GW274150 (dihydrochloride) exerts a protective role in an acute model of lung injury inflammation [3].
loading...
    loading...
Cat. No.: HY-W014109
CAS No.: 69304-49-0
Synonyms: (E)-5-(2-Bromovinyl)uracil; BVU
Target:  

DNA/RNA Synthesis

Research Areas:  

Infection

(E)-5-(2-Bromovinyl)uracil (BVU) is a pyrimidine base and an inactive metabolite of the antiviral agents sorivudine and (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) that may be regenerated to BVDU in vivo. BVU irreversibly inactivates dihydropyrimidine dehydrogenase (DPD) in an NADPH-dependent manner. It enhances the efficacy of the chemotherapeutic agent and DPD substrate 5-fluorouracil (HY-90006) in a P388 murine leukemia model when administered at a dose of 200 μmol/kg, increasing survival time.
loading...
    loading...
Cat. No.: HY-123189
CAS No.: 89139-28-6
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

LY 171859 is a D2 receptor agonist with significant reductase activity. LY 171859 exhibits enzymatic activity in the cytoplasm of liver, lung, and kidney, and also contains significant reductase activity in rat and human blood. LY 171859 has higher hepatic reductase activity in guinea pigs, followed by hamsters, rabbits, rats, and mice. The substrate of LY 171859 shows an apparent Km of 5.6 μM. The reduction reaction of LY 171859 is NADPH-dependent with an apparent Km of 14.8 μM. Only the A-side hydrogen of NADPH is incorporated in the reduction product of LY 171859. The reaction of LY 171859 is inhibited by cyanide and thiol reagents, and phenobarbital does not induce its activity in rats .
loading...
    loading...
Cat. No.: HY-P701871
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: NADPH-dependent aldose reductase GRE3; EC:1.1.1.21; AR; ; NADPH-dependent aldo-keto reductase GRE3; Xylose reductase; EC:1.1.1.430; EC:1.1.1.431; GRE3; XYL1; XYLA; YHR104W
Species:  
Others
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P701872
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: NADPH-dependent aldose reductase GRE3; EC:1.1.1.21; AR; ; NADPH-dependent aldo-keto reductase GRE3; Xylose reductase; EC:1.1.1.430; EC:1.1.1.431; GRE3; XYL1; XYLA; YHR104W
Species:  
Others
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-162677
CAS No.: 1610794-70-1
Research Areas:  

Cardiovascular Disease

MT-1207 is an orally active, selective adrenergic α1 and 5-HT2A receptor antagonist. The IC50 values of MT-1207 for α1A, α1B, α1D, and 5-HT2A are <0.1 nM, 0.15 nM, 1.40 nM, and 0.27 nM, respectively. MT-1207 induces vasodilation, improves baroreflex sensitivity, and reduces heart rate in isolated hearts. MT-1207 lowers blood pressure, protects the heart, brain, and kidneys, improves cognition, delays stroke, reduces mortality, and lowers uric acid without impairing renal function in SHR/2K1C/2K2C models. MT-1207 exhibits high plasma protein binding, resistance to plasma esterases, and NADPH-dependent hepatic metabolism. MT-1207 can be used for research related to hypertension [3].
loading...
    loading...
Cat. No.: HY-P82650
Synonyms: CBR3; Carbonyl reductase [NADPH] 3; NADPH-dependent carbonyl reductase 3

Host:  

Rabbit

Application:  

WB

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P82650A
Synonyms: CBR3; Carbonyl reductase [NADPH] 3; NADPH-dependent carbonyl reductase 3

Host:  

Rabbit

Application:  

WB

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P80590
Synonyms: 15 hydroxyprostaglandin dehydrogenase [NADP ]; 15-hydroxyprostaglandin dehydrogenase [NADP ]; Carbonyl reductase [NADPH] 1; CBR 1; CBR1; CBR1_HUMAN; CRN; NADPH dependent carbonyl reductase 1; NADPH-dependent carbonyl reductase 1; Prostaglandin 9 ketoreduc

Host:  

Mouse

Application:  

WB, ICC/IF

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-117806
CAS No.: 1388225-79-3
Research Areas:  

Cancer

TSR-011-isomer is an isomer of Belizatinib (HY-17603), a ALK inhibitor with an IC50 of 6 nM. TSR-011-isomer acts as a substrate for metabolic hydrolysis and NADPH-dependent metabolism. TSR-011-isomer undergoes enzymatic hydrolysis in mouse plasma and NADPH-dependent metabolism in mouse liver microsomes, thereby supporting clearance processes. TSR-011-isomer can be used in studies related to ALK-driven cancers .
loading...
    loading...
Cat. No.: HY-P702977
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: POR; P450R; Cytochrome P450 Oxidoreductase; CPR; CYPOR; P450 (Cytochrome) Oxidoreductase; NADPH--Cytochrome P450 Reductase; FLJ26468; NADPH--Hemoprotein Reductase; NADPH-dependent Cytochrome P450 Reductase
Species:  
Human
Source:  
Sf9 insect cells
loading...
    loading...